Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Apply
Pembrolizumab vs. Chemotherapy
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step